28251683|t|Limb remote ischaemic postconditioning - induced elevation of fibulin-5 confers neuroprotection to rats with cerebral ischaemia / reperfusion injury: Activation of the AKT pathway
28251683|a|Limb remote ischaemic postconditioning (RIPostC) is an effective and well-acknowledged treatment for brain ischaemia injury. The present study aimed to evaluate the role of fibulin-5 in the neuroprotection of RIPostC against cerebral ischaemia / reperfusion (I/R) injury in rats. The middle cerebral artery occlusion (MCAO) model was established in rats and then RIPostC was carried out by three cycles of 10 minutes occlusion /10 minutes release of the bilateral femoral artery at the beginning of the reperfusion. To downregulate the fibulin-5 level, fibulin-5 siRNA was injected into the lateral ventricle 24 hours before MCAO. According to our present study, RIPostC attenuated cerebral I / R injury by decreasing infarct volume, improving neurobehavioral score and suppressing blood brain barrier (BBB) leakage. Moreover, the mRNA and protein levels of fibulin-5 were upregulated by RIPostC at 24 hours and 72 hours after reperfusion. Downregulation of fibulin-5 attenuated the neuroprotection of RIPostC. Finally, the result showed that fibulin-5 was upregulated by RIPostC via activation of the PI3K/AKT pathway. Taken together, these results provide evidence that upregulation of fibulin-5 is involved in the beneficial effect of RIPostC against cerebral I / R injury.
28251683	0	4	Limb	T023	C0015385
28251683	5	38	remote ischaemic postconditioning	T061	C2936234
28251683	41	48	induced	T169	C0205263
28251683	49	58	elevation	T081	C0205217
28251683	62	71	fibulin-5	T116,T123	C1452861
28251683	80	95	neuroprotection	T043	C0598958
28251683	99	103	rats	T015	C0034721
28251683	109	127	cerebral ischaemia	T047	C0917798
28251683	130	148	reperfusion injury	T037	C0035126
28251683	150	160	Activation	T052	C1879547
28251683	168	179	AKT pathway	T044	C1515844
28251683	180	184	Limb	T023	C0015385
28251683	185	218	remote ischaemic postconditioning	T061	C2936234
28251683	220	227	RIPostC	T061	C2936234
28251683	267	276	treatment	T061	C0087111
28251683	281	303	brain ischaemia injury	T037	C2945681
28251683	317	322	study	T062	C2603343
28251683	353	362	fibulin-5	T116,T123	C1452861
28251683	370	385	neuroprotection	T043	C0598958
28251683	389	396	RIPostC	T061	C2936234
28251683	405	423	cerebral ischaemia	T047	C0917798
28251683	426	450	reperfusion (I/R) injury	T037	C0035126
28251683	454	458	rats	T015	C0034721
28251683	464	496	middle cerebral artery occlusion	T020	C0740391
28251683	498	502	MCAO	T020	C0740391
28251683	504	509	model	T075	C0026339
28251683	529	533	rats	T015	C0034721
28251683	543	550	RIPostC	T061	C2936234
28251683	589	596	minutes	T079	C0439232
28251683	597	606	occlusion	T020	C0740391
28251683	611	618	minutes	T079	C0439232
28251683	634	643	bilateral	T082	C0238767
28251683	644	658	femoral artery	T023	C0015801
28251683	683	694	reperfusion	T061	C0035124
28251683	699	711	downregulate	T044	C0013081
28251683	716	725	fibulin-5	T116,T123	C1452861
28251683	726	731	level	T080	C0441889
28251683	733	748	fibulin-5 siRNA	T114,T123	C1099354
28251683	753	761	injected	T061	C1533685
28251683	771	788	lateral ventricle	T030	C0152279
28251683	792	797	hours	T079	C0439227
28251683	805	809	MCAO	T020	C0740391
28251683	836	841	study	T062	C2603343
28251683	843	850	RIPostC	T061	C2936234
28251683	851	861	attenuated	T052	C0599946
28251683	862	872	cerebral I	T047	C0917798
28251683	875	883	R injury	T037	C0035126
28251683	887	897	decreasing	T033	C0442797
28251683	898	905	infarct	T046	C0021308
28251683	906	912	volume	T081	C0449468
28251683	924	945	neurobehavioral score	T081	C0449820
28251683	950	961	suppressing	T169	C1260953
28251683	962	981	blood brain barrier	T023	C0005854
28251683	983	986	BBB	T023	C0005854
28251683	988	995	leakage	T046	C0015376
28251683	1011	1015	mRNA	T114,T123	C0035696
28251683	1020	1034	protein levels	T034	C0428479
28251683	1038	1047	fibulin-5	T116,T123	C1452861
28251683	1053	1064	upregulated	T044	C0041904
28251683	1068	1075	RIPostC	T061	C2936234
28251683	1082	1087	hours	T079	C0439227
28251683	1095	1100	hours	T079	C0439227
28251683	1107	1118	reperfusion	T061	C0035124
28251683	1120	1134	Downregulation	T044	C0013081
28251683	1138	1147	fibulin-5	T116,T123	C1452861
28251683	1148	1158	attenuated	T052	C0599946
28251683	1163	1178	neuroprotection	T043	C0598958
28251683	1182	1189	RIPostC	T061	C2936234
28251683	1223	1232	fibulin-5	T116,T123	C1452861
28251683	1237	1248	upregulated	T044	C0041904
28251683	1252	1259	RIPostC	T061	C2936234
28251683	1264	1274	activation	T052	C1879547
28251683	1282	1298	PI3K/AKT pathway	T044	C1515844
28251683	1322	1329	results	T169	C1274040
28251683	1338	1346	evidence	T078	C3887511
28251683	1352	1364	upregulation	T044	C0041904
28251683	1368	1377	fibulin-5	T116,T123	C1452861
28251683	1418	1425	RIPostC	T061	C2936234
28251683	1434	1444	cerebral I	T047	C0917798
28251683	1447	1455	R injury	T037	C0035126